Forsta AP Fonden Sells 51,300 Shares of Cardinal Health, Inc. $CAH

Forsta AP Fonden trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 35.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 93,000 shares of the company’s stock after selling 51,300 shares during the quarter. Forsta AP Fonden’s holdings in Cardinal Health were worth $19,112,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after acquiring an additional 617,775 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Cardinal Health by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after purchasing an additional 43,924 shares during the period. Wellington Management Group LLP grew its stake in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares during the last quarter. Norges Bank bought a new stake in shares of Cardinal Health in the fourth quarter worth about $790,344,000. Finally, Bank of America Corp DE increased its holdings in Cardinal Health by 3.2% during the 3rd quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock valued at $563,922,000 after purchasing an additional 111,582 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 1.6%

CAH opened at $196.57 on Friday. The stock has a market cap of $46.04 billion, a PE ratio of 30.06, a PEG ratio of 1.17 and a beta of 0.53. The business has a 50 day moving average of $203.52 and a 200-day moving average of $208.79. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.

Wall Street Analyst Weigh In

Several research firms have weighed in on CAH. UBS Group set a $260.00 price objective on Cardinal Health and gave the stock a “buy” rating in a report on Friday, February 6th. Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a report on Friday, May 1st. Finally, Mizuho upped their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.